Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10853660rdf:typepubmed:Citationlld:pubmed
pubmed-article:10853660lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:10853660lifeskim:mentionsumls-concept:C0014544lld:lifeskim
pubmed-article:10853660lifeskim:mentionsumls-concept:C0028754lld:lifeskim
pubmed-article:10853660lifeskim:mentionsumls-concept:C0243192lld:lifeskim
pubmed-article:10853660lifeskim:mentionsumls-concept:C0289174lld:lifeskim
pubmed-article:10853660lifeskim:mentionsumls-concept:C0528200lld:lifeskim
pubmed-article:10853660lifeskim:mentionsumls-concept:C0034423lld:lifeskim
pubmed-article:10853660lifeskim:mentionsumls-concept:C0302350lld:lifeskim
pubmed-article:10853660lifeskim:mentionsumls-concept:C0185125lld:lifeskim
pubmed-article:10853660lifeskim:mentionsumls-concept:C0243072lld:lifeskim
pubmed-article:10853660pubmed:issue9lld:pubmed
pubmed-article:10853660pubmed:dateCreated2000-11-15lld:pubmed
pubmed-article:10853660pubmed:abstractTextA series of pyrrolo[3,2,1-ij]quinoline derivatives was synthesized, evaluated for their activity against the 5-HT2c and 5-HT2a, receptors and found to be agonists at 5-HT2c with selectivity over 5-HT2a.lld:pubmed
pubmed-article:10853660pubmed:languageenglld:pubmed
pubmed-article:10853660pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10853660pubmed:citationSubsetIMlld:pubmed
pubmed-article:10853660pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10853660pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10853660pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10853660pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10853660pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10853660pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10853660pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10853660pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10853660pubmed:statusMEDLINElld:pubmed
pubmed-article:10853660pubmed:monthMaylld:pubmed
pubmed-article:10853660pubmed:issn0960-894Xlld:pubmed
pubmed-article:10853660pubmed:authorpubmed-author:MacLeanNNlld:pubmed
pubmed-article:10853660pubmed:authorpubmed-author:EdwardsLLlld:pubmed
pubmed-article:10853660pubmed:authorpubmed-author:IsaacMMlld:pubmed
pubmed-article:10853660pubmed:authorpubmed-author:O'BrienAAlld:pubmed
pubmed-article:10853660pubmed:authorpubmed-author:LeeD KDKlld:pubmed
pubmed-article:10853660pubmed:authorpubmed-author:DemchyshynLLlld:pubmed
pubmed-article:10853660pubmed:authorpubmed-author:McCallumKKlld:pubmed
pubmed-article:10853660pubmed:authorpubmed-author:KambojRRlld:pubmed
pubmed-article:10853660pubmed:authorpubmed-author:SlassiAAlld:pubmed
pubmed-article:10853660pubmed:authorpubmed-author:BueschkensDDlld:pubmed
pubmed-article:10853660pubmed:authorpubmed-author:De LannoyIIlld:pubmed
pubmed-article:10853660pubmed:issnTypePrintlld:pubmed
pubmed-article:10853660pubmed:day1lld:pubmed
pubmed-article:10853660pubmed:volume10lld:pubmed
pubmed-article:10853660pubmed:ownerNLMlld:pubmed
pubmed-article:10853660pubmed:authorsCompleteYlld:pubmed
pubmed-article:10853660pubmed:pagination919-21lld:pubmed
pubmed-article:10853660pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:10853660pubmed:meshHeadingpubmed-meshheading:10853660...lld:pubmed
pubmed-article:10853660pubmed:meshHeadingpubmed-meshheading:10853660...lld:pubmed
pubmed-article:10853660pubmed:meshHeadingpubmed-meshheading:10853660...lld:pubmed
pubmed-article:10853660pubmed:meshHeadingpubmed-meshheading:10853660...lld:pubmed
pubmed-article:10853660pubmed:meshHeadingpubmed-meshheading:10853660...lld:pubmed
pubmed-article:10853660pubmed:meshHeadingpubmed-meshheading:10853660...lld:pubmed
pubmed-article:10853660pubmed:meshHeadingpubmed-meshheading:10853660...lld:pubmed
pubmed-article:10853660pubmed:meshHeadingpubmed-meshheading:10853660...lld:pubmed
pubmed-article:10853660pubmed:meshHeadingpubmed-meshheading:10853660...lld:pubmed
pubmed-article:10853660pubmed:meshHeadingpubmed-meshheading:10853660...lld:pubmed
pubmed-article:10853660pubmed:meshHeadingpubmed-meshheading:10853660...lld:pubmed
pubmed-article:10853660pubmed:meshHeadingpubmed-meshheading:10853660...lld:pubmed
pubmed-article:10853660pubmed:year2000lld:pubmed
pubmed-article:10853660pubmed:articleTitlePyrrolo[3,2,1-ij]quinoline derivatives, a 5-HT2c receptor agonist with selectivity over the 5-HT2a receptor: potential therapeutic applications for epilepsy and obesity.lld:pubmed
pubmed-article:10853660pubmed:affiliationNPS Allelix Corp., Mississauga, ON, Canada. misaac@allelix.comlld:pubmed
pubmed-article:10853660pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:10853660lld:chembl